Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD:

Klaus F. Rabe, M.D., Ph.D., Fernando J. Martinez, M.D., Gary T. Ferguson, M.D., Chen Wang, M.D., Ph.D., Dave Singh, M.D., Jadwiga A. Wedzicha, M.D., Roopa Trivedi, M.S., Earl St. Rose, M.S., Shaila Ballal, M.S., Julie McLaren, M.D., Patrick Darken, Ph.D., Magnus Aurivillius, M.D., Ph.D., et al.,

2 July, 2020

NZ Respiratory Research Review Issue 180

Association Between Initiation of Pulmonary Rehabilitation After Hospitalization for COPD and 1-Year Survival Among Medicare Beneficiaries:

Peter K. Lindenauer, MD, MSc, Mihaela S. Stefan, MD, PhD, Penelope S. Pekow, PhD, et al

12 May, 2020

NZ Respiratory Research Review Issue 180

Lung Function Trajectories Leading to Chronic Obstructive Pulmonary Disease as Predictors of Exacerbations and Mortality:

Jacob Louis Marott, Truls Sylvan Ingebrigtsen, Yunus Çolak, Jørgen Vestbo, and Peter Lange

24 March, 2020

NZ Respiratory Research Review Issue 180

Diffusing Capacity Is an Independent Predictor of Outcomes in Pulmonary Hypertension Associated With COPD:

Aparna Balasubramanian, MD Todd M. Kolb, MD, PhD Rachel L. Damico, MD, PhD Paul M. Hassoun, MD Meredith C. McCormack, MD Stephen C. Mathai, MD

14 March, 2020

NZ Respiratory Research Review Issue 180

Effect of Olfactory Stimulation by L-Menthol on Laboratory-Induced Dyspnea in COPD:

Masashi Kanezaki, PT, PhD Kunihiko Terada, MD, PhD Satoru Ebihara, MD, PhD

22 January, 2020

NZ Respiratory Research Review Issue 180

A Geographic Analysis of Racial Disparities in Use of Pulmonary Rehabilitation After Hospitalization for COPD Exacerbation:

Kerry A. Spitzer, PhD, MPA Mihaela S. Stefan, MD, PhD Aruna Priya, MA, MSc Victor M. Pinto-Plata, MD Richard L. ZuWallack, MD Peter K. Lindenauer, MD et al

17 January, 2020

NZ Respiratory Research Review Issue 180

Pulmonary rehabilitation for people with chronic obstructive pulmonary disease (COPD): a grounded theory investigation:

Levack, W.

9 March, 2016

PR has been shown to improve physical function, improve quality of life, and reduce hospital readmission rates in people with COPD. However, less than 1% of the approximately 275,000 people with COPD in NZ attend PR each year.

Health, happiness and community:

McNaughton, A

5 November, 2015

The Sing Your Lungs Out study has looked at the impact that participation in a community singing group has on the respiratory function and health of patients with COPD. Presented to the Respiratory Conference New Zealand in November 2015

The impact of respiratory disease in New Zealand: 2014 update:

Telfar Barnard, L., Baker, M., Pierse, N., & Zhang, J.

4 April, 2015

This report covers six respiratory disease indicators: asthma, bronchiectasis, childhood bronchiolitis and pneumonia, chronic obstructive pulmonary disease (COPD), and total respiratory disease.

Challenges for Tokelau families with family members with asthma or COPD in maintaining a healthy environment:

Pene, G.

26 August, 2013

We spend more than 75% of our time indoors, so keeping the houses of people with asthma and COPD warm and dry is crucial for maintaining their health.